Functional genomics of osteoarthritis

Pharmacogenomics

Volumn 3, Issue 5, 2002, Pages 635-650

  Aigner, Thomas ^a   Bartnik, Eckart ^a   Zien, Alexander ^a   Zimmer, Ralf ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Bioinformatics; Cartilage; Chondrocyte development; Differentiation; Functional genomics; Matrix degradation; Normalization; Osteoarthritis; Target genes

Indexed keywords

BIOLOGICAL MARKER; COLLAGENASE 3; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GELATINASE A; GROWTH FACTOR; INTERLEUKIN 1BETA; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN C FOS; PROTEINASE; RECOMBINANT PROTEIN; RIBOSOME RNA; RNA; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; VAV PROTEIN;

ARTICULAR CARTILAGE; AUTOMATION; BIOINFORMATICS; BIOSTATISTICS; CARTILAGE CELL; CARTILAGE MATRIX; CELL ACTIVITY; CELL DEGENERATION; CELL PROLIFERATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC SCREENING; GENOMICS; HEALTH ECONOMICS; HUMAN; IN VIVO STUDY; MEDICAL TECHNOLOGY; NONHUMAN; OSTEOARTHRITIS; PATHOGENICITY; QUALITY OF LIFE; RELIABILITY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; TARGET CELL; TISSUE METABOLISM; VALIDATION PROCESS;

ANIMALS; GENOMICS; HUMANS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 0036742297     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.3.5.635     Document Type: Review

References (74)

1. Aigner T, McKenna LA: Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol. Life Sci. 59, 5-18 (2002).
2. Cancedda R, Descalzi-Cancedda F, Castagnola P: Chondrocyte differentiation. Int. Rev. Cytol. 159, 265-358 (1995).
3. Aigner T, Dertinger S, Vornehm SI, Dudhia J, von der Mark K, Kirchner T: Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am. J. Pathol. 150, 2133-2141 (1997).
4. Mankin HJ, Johnson ME, Lippiello L: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. III. Distribution and metabolism of amino sugar-containing macromolecules. J. Bone Joint Surg. 63A1, 131-139 (1981).
5. Mitrovic D, Gruson M, Demignon J, Mercier P, Aprile F, de Seze S: Metabolism of human femoral head cartilage in osteoarthrosis and subcapital fracture. Ann. Rheum. Dis. 40, 18-26 (1981).
6. Rizkalla G, Reiner A, Bogoch E, Poole AR: Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. J. Clin. Invest. 90, 2268-2277 (1992).
7. Grushko G, Schneiderman R, Maroudas A: Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Conn. Tiss. Res. 19, 149-176 (1989).
8. Aigner T, Vornehm SI, Zeiler G, Dudhia J, von der Mark K, Bayliss MT: Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. 40, 562-569 (1997).
9. Aigner T, Stöβ H, Weseloh G, Zeiler G, von der Mark K: Activation of collagen Type II expression in osteoarthritic and rheumatoid cartilage. Virchows Archiv B 62, 337-345 (1992).
10. Lippiello L, Hall MD, Mankin HJ: Collagen synthesis in normal and osteoarthrotic human cartilage. J. Clin. Invest. 59, 593-600 (1977).
11. Girkontaité I, Frischholz S, Lammi P et al.: Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol. 15, 231-238 (1996).
12. Aigner T, Bertling W, Stöβ H, Weseloh G, von der Mark K: Independent expression of fibril-forming collagens I, II and III in chondrocytes in human osteoarthritic cartilage. J. Clin. Invest 91, 829-837 (1993).
13. Aigner T, Zhu Y, Chanksi H, Matsen FA, Maloney WJ, Sandell LJ: Reexpression of procollagen Type IIA by adult articular chondrocytes in ostcoarthritis cartilage. Arthritis Rheum. 42, 1443-1450 (1999).
14. Gebhard PM, Gehrsirz A, Bau B, Söder S, Eger W, Aigner T: Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J. Ortho. Res. In press (2002).
15. Macilwain C: World leaders heap praise on human genome landmark. Nature 405, 983-984 (2000).
16. Vukmirovic OG, Tilghman SM: Exploring genome space. Nature 405, 820-822 (2000).
17. Howard K: The bioinformatics gold rush. Sci. Am. 283, 58-63 (2000).
18. Ezzell C: Beyond the human genome. Sci. Am. 283, 64-69 (2000).
19. Eisenberg D, Marcotte EM, Xenarios I, Yeates TO: Protein function in the postgenomic era. Nature 405, 823-826 (2000).
20. Pandey A, Mann M: Proteomics to study genes and genomes. Nature 405, 837-846 (2000).
21. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998).
22. Stokes DG, Liu G, Coimbra IB, Velazquez S, Crowl RM, Jimenez SA: Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum. 46, 404-419 (2002).
23. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna LA: Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum. 44, 2777-2789 (2001).
24. Attur MG, Dave MN, Leung MY et al.: Functional genomic analysis of type II IL- 1? decoy receptor: potential for gene therapy in human arthritis and inflammation. J. Immunol. 168, 2001-2010 (2002).
25. Rose CS, Malcolm S: A TWIST in development. Trends Genet. 13, 384-387 (1997).
26. Fuchtbauer EM: Expression of M-twist during postimplantation development of the mouse. Dev. Dyn. 204, 316-322 (1995).
27. Grant EP, Pickard MD, Briskin MJ, Gutierrez Ramos J-C: Gene expression profiles. Creating new perspectives in arthritis research. Arthritis Rheum 46, 874-884 (2002).
28. Schulze A, Downward J: Navigating gene expression using microarrays-a technology review. Nat. Cell Biol. 3, E190-E195 (2001)
29. Quackenbush J: Computational analysis of microarray data. Nat. Rev. Genet. 2, 418-427 (2001).
30. Lockhart DJ, Winzeler EA: Genomics, gene expression and DNA array. Nature 405, 827-836 (2000).
31. Lee PD, Sladek R, Greenwood CM, Hudson TJ: Control genesand variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies. Genome Res. 12, 292-297 (2002).
32. Zien A, Aigner T. Zimmer R, Lengauer T: Centralization: a new paradigm for the normalization of gene expression data. Bioinformatics 17, S323-S331 (2001).
33. Hoffmann R, Seidl T, Dugas M: Profound effect of normalization on detection of differentially expressed genes in oligonucleotide microarray data analysis. Genome Biol 3 (2002).
34. Lee CK, Mopp RG, Weindruch R, Prolla TA: Gene expression profile of ageing and its retardation by caloric restriction. Science 285, 1390-1393 (1999).
35. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T: Relative mRNA expression profiling of 'collagenases' and 'aggrecanases' in human articular chondrocytes in vivo and in vitro. Arthritis Rheum. In press (2002).
36. Billinghurst RC, Dahlberg L, Ionescu M et al.: Enhanced cleavage of Type II Collagen by collagenase in osteoarthritic articular cartitage. J. Clin. Invest. 99, 1534-1545 (1997).
37. Mitchell PG, Magna HA, Reeves LM et al.: Cloning, expression and Type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest 97, 761-768 (1996).
38. Shlopov BV, Lie W-R, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA: Ostcoarthritic lesions - involvement of three different collagenases. Arthritis Rheum. 40, 2065-2074 (1997).
39. Repo RU, Mitchell NS: Collagen synthesis in mature articular cartilage of the rabbit. J. Bone Joint Surg. 53-B, 541-548 (1971).
40. Maroudas A: Physicochemical properties of articular cartilage. In: Adult Articular Cartilage (Edition 2). Freeman MAR (Ed), Tunbridge Wells, Pitman Medical Publishing, UK 215-290 (1980).
41. Cawston T, Billington C, Cleaver C et al.: The regulation of MMPs and TIMPs in cartilage turnover. Ann. NY Acad. Sci. 878, 120-129 (1999).
42. Ishiguro N, Ito T, Ito H et al.: Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover. Arthritis Rheum. 42, 129-136 (1999).
43. Salter DM: Tenascin is increased in cartilage and synovium from ostcoarthritic knees. Br .J Rheumatol. 32, 780-786 (1993).
44. Rocke DM, Durbin B: A model for measurement error for gene expression arrays. J. Comput. Biol. 8, 557-569 (2001).
45. Ben Dor A, Bruhn L, Friedman N, Nachman I, Schummer M, Yakhini Z: Tissue classification with gene expression profiles. J. Comput. Biol. 7, 559-583 (2000).
46. Manduchi E, Grant GR, McKenzie SE, Overton GC, Surrey S, Stoeckert CJ Jr: Generation of patterns from gene expression data by assigning confidence to differentially expressed genes. Bioinformatics 16, 685-698 (2000).
47. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279-284 (2001).
48. Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H, Guilak F: Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys. Res. Commun. 290, 763-769 (2002).
49. Connor JR, Dodds RA, Emery JG, Kirkpatrick RB, Rosenberg M, Gowen M: Human articular cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblysts and osteocytes by in situ hybridization. Osteoarthritis Cartilage 8, 87-95 (2000).
50. Boot RG, Renkema GH, Strijland A, Van Zonneveld AJ, Aerts JMFG: Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J. Biol. Chem. 270, 26252-26256 (1995).
51. Hakala BE, White C, Recklies AD: Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J. Biol. Chem. 34, 25803-25810 (1993).
52. Garnero P, Rousseau JC, Delmas PD: Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases. Arthritis Rheum, 43, 953-968 (2000).
53. de Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P: YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys. Res. Commun. 285, 926-931 (2001).
54. Aigner T, Hemmel M, Neureiter D et al.: Apoptotic cell death is not a widespread phenomenon in normal ageing and osteoarthritic human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis) and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum. 44, 1304-1312 (2001).
55. Li L, Weinberg CR, Darden TA, Pedersen LG: Gene selection for sample classification based on gene expression data: study of sensitivity to choice of parameters of the GA/KNN method. Bioinformatics 17, 1131-1142 (2001).
56. Xiong M, Fang X, Zhao J: Biomarker identification by feature wrappers. Genome Res. 11, 1878-1887 (2001).
57. Ideker T, Thorsson V, Ranish JA et al.: Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292, 929-934 (2001).
58. Zien A, Küffner R, Zimmer R, Lengauer T: Analysis of gene expression data with pathway scores. Proc. Int. Conf. Intell. Syst. Mol. Biol. 8, 407-417 (2000).
59. Kuffner R, Zimmer R, Lengauer T: Pathway analysis in metabolic databases via differential metabolic display (DMD). Bioinformatics 16, 825-836 (2000).
60. Lozada CJ, Altman RD: Animal models of cartilge breakdown. In: Dynamics of bone and cartilage metabolism. 339-352 (1999).
61. Goldring MB, Birkhead JR, Sandell LJ, Kimura T, Krane SM: Interleukin-1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J. Clin. Invest. 82, 2026-2037 (1988).
62. von der Mark K, Gauss V, von der Mark H, Müller PK: Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature 267, 531-532 (1977).
63. Benya PD, Shaffer JD: Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215-224 (1982).
64. Kolettas E, Buluwela L, Bayliss MT. Muir HI: Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes. J. Cell Sci. 108, 1991-1999 (1995).
65. Tyler JA: Articular cartilage cultured with catabolin (pig interleukin-1) synthesizes decreased number of normal proteoglycan molecules. Biochem. J. 227, 869-878 (1985).
66. Hui A, Min WX, Tang J, Cruz TF: Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes. Arthritis Rheum. 41, 869-876 (1998).
67. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE: Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43, 801-811 (2000).
68. Hofmann TG, Hehner SP, Droge W, Schmitz ML: Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription. Oncogene 19, 1153-1163 (2000).
69. Vincenti MP, Brinckerhoff CE: Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1 beta. Arthritis Res. 3, 381-388 (2001).
70. Häuselmann HJ, Fernandes RJ, Mok SS et al.: Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J. Cell Sci. 107, 17-27 (1994).
71. Golub TR, Slonim DK, Tamayo P et al.: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531 -537 (1999).
72. Yoshihara Y, Nakamura H, Obata K et al.: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59, 455-461 (2000).
73. Petersson IF, Sandqvist L, Svensson B, Saxne T: Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann. Rheum. Dis. 56, 64-67 (1997).
74. Kloos DU, Choi C, Wingender E: The TGF-beta-Smad network: introducing bioinformatic tools. Trends Genet. 18, 96-103 (2002).